Royal jelly (RJ) produced by honey bees is known to contain three major nutrients including amino acids, vitamins and minerals.
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
Yoshito ZAMAMI, a Shingo TAKATORI, b Mitsuhiro GODA, a Toshihiro KOYAMA, a Yukiko IWATANI, weeks of age. Biochemical Analysis Under light ether anesthesia, blood samples were obtained 0.8 ml from the heart by cardiopuncture after 12-h fasting. A drop of the blood sample was immediately used to measure the plasma level of glucose with a glucose analyzer (ADVANTAGE; Boehringer Mannheim, Tokyo, Japan). Blood samples were centrifuged to obtain plasma samples, which was stored at Ϫ80°C until the measurements. Plasma insulin was measured by a double-antibody method using a solid-phase insulin monoclonal antibody and a guinea pig insulin antibody with an ELISA insulin kit (Morinaga Biochemistry Co., Kanagawa, Japan). Plasma cholesterol and triglyceride were enzymatically measured using commercially available kits (Wako Pure Chemical Industries, Ltd., Osaka, Japan). The effects of RJ were expressed as a ratio of the value obtained from 14 week-old rats or the value from 6 week-old rats. The Homeostasis Model Assessment ratio (HOMA-R), which is an index of insulin resistance, was calculated using this formula: plasma glucose (mmol/l)ϫinsulin (mU/ml)/22.5.
13)
Systolic Blood Pressure (SBP) Measurement SBP under the conscious state was measured with a tail-cuff plethysmograph (TK-370C, Unicom, Tokyo, Japan) from 6 to 14 weeks of age once a week. The average of five readings per animal was used.
Perfusion of Mesenteric Vascular Beds
The animals in the 14 week-old control group, FDR without RJ administration group and FDR with RJ administration group were anesthetized with pentobarbital-Na (50 mg/kg, intraperitoneally) and mesenteric vascular beds were isolated and prepared for perfusion as described previously. 14) After removal of the entire intestine and associated vascular bed, the mesenteric vascular bed was separated from the intestine by cutting close to the intestinal wall. Only four main arterial branches from the superior mesenteric trunk running to the terminal ileum were perfused. All other branches of the superior mesenteric arteries were tied off. The isolated mesenteric vascular was placed in a water-jacketed organ bath maintained at 37°C, perfused with a modified (see below) Krebs solution at a constant flow rate of 5 ml/min with a peristaltic pump (model AC-2120, ATTO, Tokyo, Japan) and superfused with the same solution at a rate of 0.5 ml/min to prevent drying. The Krebs solution was bubbled with a mixture of 95% O 2 -5% CO 2 before passage through a warming coil maintained at 37°C. The modified Krebs solution was of the following composition (mM): NaCl 119.0, KCl 4.7, CaCl 2 2.4, MgSO 4 1.2, NaHCO 3 25.0, KH 2 PO 4 1.2, disodium EDTA 0.03 and dextrose 11.1 (pH 7.4). Changes in the perfusion pressure were measured with a pressure transducer (model TP-400T, Nihon Koden, Tokyo, Japan) and recorded using a pen recorder (model U-228, Nihon Denki Kagaku, Tokyo, Japan).
Perfusion Experimental Protocol After 30 minutes' perfusion, isolated mesenteric vascular beds with resting tone were subjected to periarterial nerve stimulation (PNS) (8, 12 Hz) and bolus injection of norepinephrine (NE) (5, 10 nmol), which induced an increase in perfusion pressure due to vasoconstriction. Thereafter, Krebs solution was switched to Krebs solution containing 5 mM guanethidine and 7 mM methoxamine to increase the perfusion pressure to about 100 mmHg levels. After elevated perfusion pressure stabilized, PNS (2, 4 Hz) and a bolus injection of rat CGRP (50, 100 pmol) were applied to decrease the perfusion pressure due to vasodilation. PNS was performed using bipolar platinum ring electrodes placed around the superior mesenteric artery. Rectangular pulses of 1 ms and a supramaximal voltage (50 V) were applied for 30 s via an electronic stimulator (model SEN 3301; Nihon Bunko). NE was directly injected into the perfusate proximal to the arterial cannula with an infusion pump (model 975; Harvard Apparatus Inc., Holliston, MA, U.S.A.). A volume of 100 ml was injected over a period of 12 s. At the end of each experiment, 100 mM papaverine was perfused to produce complete relaxation. Vasoconstrictions were expressed as the increase in perfusion pressure. Vasodilations were expressed as the percent perfusion pressure at maximum relaxation induced by papaverine.
Statistical Analysis The experimental results are presented as the meanϮS.E.M. Statistical analyses were performed using one analysis of variance (ANOVA) followed by Tukey's test or two-way ANOVA, when appropriate. pϽ0.05 was considered statistically significant.
RESULTS

Effects of 8-Week Treatment with RJ on Body Weight
and Food and Liquid Intake in FDR As shown in Table  1 , food intake in the vehicle-treated FDR group was significantly lower than that in the control group, while liquid intake in the vehicle-treated FDR group was significantly higher than that in the control group. However, there was no significant difference in food or liquid intake between the vehicle-treated and RJ-treated FDR groups ( Table 1) .
As shown in Fig. 1 , there was no significant difference in body weight between the control group and vehicle-or RJtreated FDR (Fig. 1 ). Figure  2 shows changes in fasting blood glucose (A), fasting serum insulin level (B) and the index of insulin resistance (HOMA) (C) of FDR before and after 8-week treatment with RJ or the vehicle. The plasma glucose levels in the control, vehicletreated, RJ 100 mg/kg-treated and RJ 300 mg/kg-treated FDR at 6 weeks of age before fructose-loading were 88Ϯ5 mg/dl, 92Ϯ6 mg/dl, 92Ϯ4 mg/dl, and 98Ϯ5 mg/dl, respectively. Plasma glucose levels at 14 weeks of age in the control and vehicle-treated FDR groups were significantly higher than those at 6 weeks of age. However, there was no significant difference in the plasma glucose levels between vehicle-and RJ-treated FDR ( Fig. 2A) .
Effects of 8-Week Treatment with RJ on Plasma Levels of Insulin, Glucose and the HOMA Score in FDR
At 6 weeks of age before fructose-loading, serum insulin levels in the control, vehicle-treated, RJ 100 mg/kg-treated FDR and RJ 300 mg/kg-treated FDR were 0.27Ϯ0.03 ng/ml, 0.26Ϯ0.02 ng/ml, 0.34Ϯ0.03 ng/ml, 0.29Ϯ0.03 ng/ml, respectively. There was no significant difference between each group. Serum insulin levels in vehicle-treated FDR at 14 weeks of age after 15% fructose-loading were about two times higher than controls at 14 weeks of age and vehicletreated FDR at 6 weeks of age before fructose-loading, indicating hyperinsulinemia in vehicle-treated FDR at 14 weeks of age. As shown in Fig. 2A , RJ treatment for 8 weeks induced a dose-dependent decrease in serum insulin levels. The plasma insulin level in the RJ 300 mg/kg-treated FDR group at 14 weeks of age was significantly lower than that in vehicle-treated FDR, and was similar to that in the control group (Fig. 2B) .
As shown in Fig. 2C , the HOMA score (index of insulin resistance) in vehicle-treated FDR at 14 weeks of age was about 7 times higher than that in vehicle-treated FDR at 6 weeks of age before 15% fructose-loading and about 2 times higher than that in the control group at 14 weeks of age, indicating that insulin resistance had developed in FDR. RJ treatment for 8 weeks dose-dependently decreased the HOMA score. The HOMA score in RJ 300 mg/kg-treated FDR at 14 weeks of age was significantly lower than that in vehicletreated FDR, and was similar to that in the control group (Fig. 2C) . Figure 3 shows the effects of 8-week treatment with RJ on fasting serum total cholesterol (A) and fasting serum triglyceride (B) in FDR. At 6 weeks of age before fructose-loading, the plasma levels of total cholesterol in the control, vehicletreated FDR, RJ 100 mg/kg-treated FDR and RJ 300 mg/kgtreated FDR groups were 88Ϯ5 mg/ml, 94Ϯ10 mg/ml, 90Ϯ8 mg/ml, 91Ϯ7 mg/ml, respectively. There was no significant difference between each group. In RJ-treated FDR at 14 weeks of age, the plasma levels of total cholesterol were similar to those in control and vehicle-treated FDR. There was no significant difference in the plasma levels of total cholesterol among all groups (Fig. 3A) .
Effects of 8-Week Treatment with RJ on Plasma Levels of Triglycerides and Total Cholesterol in FDR
At 6 weeks of age before fructose-loading, the plasma levels of triglycerides in the control, vehicle-treated FDR, RJ 100 mg/kg-treated FDR and RJ 300 mg/kg-treated FDR groups were 65Ϯ2 mg/ml, 58Ϯ8 mg/ml, 55Ϯ3 mg/ml, 59Ϯ4 mg/ml, respectively. There was no significant difference between each group.
After fructose-loading, the plasma level of triglycerides in the vehicle-treated FDR group was significantly higher than that in the control group. The 8-week treatment with RJ caused a dose-dependent decrease in plasma levels of triglycerides. The plasma triglycerides level in RJ 300 mg/kgtreated FDR at 14 weeks of age was significantly lower than that in vehicle-treated FDR (Fig. 3B) .
Effect of 8-Week Treatment with RJ on Systolic BP in FDR As shown in Fig. 4 , 15% fructose-loading for 8 weeks induced a significant increase in systolic blood pressure. The systolic blood pressure in the RJ 300 mg/kg-treated FDR group tended to be lower than that in the vehicle-treated FDR group, but there was no significant difference between the RJ-treated and vehicle-treated FDR groups (Fig. 4) .
Effect of 8-Week Treatment with RJ on Adrenergic Nerve-Mediated Vasoconstrictor Responses to PNS and Bolus Injection of Norepinephrine in FDR PNS at 8 and 12
Hz of the perfused mesenteric vascular beds with resting tone produced frequency-dependent vasoconstriction. In the same preparation with resting tone, bolus injection of norepinephrine caused a concentration-dependent vasoconstriction pattern that mimicked the PNS-induced response. As shown in Fig. 5 , vasoconstrictor responses to PNS at 8 and 12 Hz in preparations isolated from the vehicle-treated FDR group were significantly greater than those in preparations from the control group. The vasoconstrictor responses to PNS in preparations from the RJ 100 and 300 mg/kg-treated FDR groups were significantly smaller than those in preparations from the vehicle-treated FDR group. However, no significant difference in vasoconstrictor responses to norepinephrine injection was found among all of the groups (Fig. 5) .
Effect of 8-Week Treatment with RJ on CGRPergic Nerve-Mediated Vasodilator Responses to PNS and Bolus Injection of CGRP in FDR
To observe the vasodilator response, active tone was achieved by continuous perfusion of methoxamine (7 mM; a 1 -adrenergic receptor agonist) in the presence of guanethidine (5 mM; adrenergic neuron blocker), which was added to block adrenergic neurotransmission. In this preparation, PNS at 2 and 4 Hz caused frequency-dependent vasodilations. As shown in Fig. 6 , the PNS (2 and 4 Hz)-induced vasodilator responses in preparations from vehicle-treated FDR tended to be smaller than those of the control group, but no significant difference was found between the two groups. CGRPergic mediated-vasodilation in preparations from RJ-treated FDR groups was similar to that in preparations from the control group, but there was no significant difference between control and RJ-treated FDR groups (Fig. 6) . In preparations from RJ-treated FDR groups (Fig.  6) , vasodilator responses to CGRP injection were similar to those in preparations from control and vehicle-treated FDR groups.
DISCUSSION
In the present study, FDR given 15% fructose solution as their drinking water showed a marked increase in plasma levels of insulin (hyperinsulinemia) and triglycerides (hypertriglyceridemia) without a significant increase in blood glucose levels (euglycemia), when compared with the vehicletreated control group. These findings are in good accordance with previous reports. 10, 11) Recently, we demonstrated that the treatment of FDR with an insulin-sensitizing drug, pioglitazone, normalized hyperinsulinemia in FDR without changing plasma glucose levels and abolished insulin resistance. 11) In addition to hyperinsulinemia, FDR developed hypertension, which has also been shown to be abolished by pioglitazone.
11) Taken together, it is very likely that FDR have insulin resistance and are a good animal model at insulin resistance.
It should be noted that 8-week treatment of FDR with RJ eliminated hyperinsulinemia and hypertriglyceridemia without changing the plasma glucose level, strongly suggesting that RJ has a potent ability to improve hyperinsulinemia and insulin resistance in FDR. Insulin resistance has been shown to be associated with changes in levels of oxidative stress. [14] [15] [16] Furthermore, recent reports suggests that RJ has protective effects against oxidative stress-induced biologic dysfunction. 17, 18) Thus, it is likely that RJ ameliorates insulin resistance via antioxidative effect. Additionally, the RJtreated FDR showed decreased SBP, while the non-treated FDR showed maintained hypertension. Therefore, the present findings imply that RJ may be effective to hypertension associated with insulin resistance. The vasoconstrictor response to PNS in the rat mesenteric artery is mediated by activation of sympathetic adrenergic nerves, since a neurotoxin (tetrodotoxin), an adrenergic neuron blocker (guanethidine), an adrenergic neurotoxin (6-hydroxydopamine) and an a 1 -adrenoceptor antagonist (prazosin) abolished the response. 19, 20) The present study demonstrated that the PNS-induced pressor response in the mesenteric artery of FDR with insulin resistance was significantly greater than that of control rats. However, FDR showed an unchanged pressor response to exogenously applied noradrenaline, which is mediated by the postsynaptic a 1 -adrenoceptor. Therefore, it is very likely that the neurotransmitter noradrenaline release from sympathetic nerve terminals is augmented in the chronic hyperinsulinemic state. Our previous in vivo studies indicated that chronic hyperinsulinemia produced by fructose drinking resulted in potentiation of sympathetic nerve-mediated vasoconstrictor responses. 10, 11) Thus, it appears that the augmented pressor response in FDR mainly results from chronic hyperinsulinemia, which increases the sympathetic nerve activity and vasoreactivity of the blood vessels. Very important findings from the present study include the facts that the treatment of FDR with RJ for 8 weeks abolished the hyperinsulinemic state, resulting in significant attenuation of augmented vasoconstriction in response to PNS in the hyperinsulinemic state. Takatori et al. 11) reported that pioglitazone treatment ameliorated augmented adrenergic nerve-mediated vasoconstriction in FDR. Taken together, it is likely that RJ has the ability to improve altered adrenergic nerve function by inhibiting insulin resistance development.
The vasodilator response to PNS has been shown to be mediated by the CGRP-containing vasodilator nerve, since the response is blocked by CGRP (8-37), a CGRP receptor antagonist, and capsaicin, which causes CGRP depletion in CGRPergic nerves. 21, 22) Bolus injections of CGRP also induced concentration-dependent vasodilation, which has been shown to be mediated by postsynaptic CGRP receptors. 23) The present study showed that the vasodilator response to PNS in the mesenteric artery of FDR tends to be suppressed when compared with control rats. Our previous in vivo study showed that chronic hyperinsulinemia induced by fructose drinking resulted in a marked reduction of the vasodilatation mediated by CGRPergic nerve stimulation. 10, 11) The present findings that the CGRPergic nerve-mediated, but not exogenous CGRP-induced, vasodilator responses in FDR were smaller than those in control rats suggest that CGRPergic nerve activity, probably the transmitter (CGRP) release, is decreased in the mesenteric artery of FDR. In the present study, treatment of FDR with RJ restored the blunted CGRPergic nerve-mediated vasodilator response without affecting the exogenous CGRP-induced response. Previous in vitro studies reported that sympathetic adrenergic nerves and CGRPergic nerves reciprocally control the vascular tone of mesenteric resistance arteries in the rat.
24) The PNS-induced vasoconstriction in mesenteric arteries is considered to result from activation of both sympathetic nerves and CGRPergic nerves, and to be attenuated by the simultaneous activation of CGRPergic nerves. Therefore, it is more likely that the restored vasoconstriction in response to PNS observed in the RJ-treated FDR results in part from the improved vasodilatation mediated by CGRPergic nerves.
In conclusion, the present study suggests that RJ is a food with health-promoting benefits, containing bioactive substances that improve not only insulin resistance, but also hypertension via indirectly vascular control dysfunction regulated by adrenergic and CGRPergic nerves in the hyperinsulinemic state. Additionally, the present study suggests that daily RJ intake would be effective to prevent the development of insulin resistance and hypertension.
